𝐒𝐤𝐢𝐧 𝐒𝐮𝐛𝐬𝐭𝐢𝐭𝐮𝐭𝐞𝐬 𝐋𝐞𝐝 𝐭𝐡𝐞 𝐖𝐨𝐮𝐧𝐝 𝐂𝐚𝐫𝐞 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭

As per a statement by a market research firm, P&S Intelligence, wound care biologics market is experiencing growth, and it will continue to grow in the years to come.

North America will be the leader of the industry. This has a lot to do with the increasing elderly population, innovation in wound care biologics, augmented contribution of private and public organizations in increasing consciousness on wound care, and the increasing count of burn cases.

Furthermore, the increasing occurrence of ulcers and growing keenness of patients for cutting-edge wound care products that have negligible side-effects and graft rejection are resultant in the high acceptance of wound care biologics in the region.

The industry will grow the fastest in the APAC region, mostly because of tech innovations, increasing elderly population, increasing count of burn cases and traumatic wounds, and increasing occurrence of chronic wounds. Asa per the World Population Ageing 2017, Asia witnessed a two-fold increase in its elderly population, with the people over the age of 60 years will reach to about 1.3 billion by 2050.

Additionally, as per the IDF, diabetes cases will reach 183 million by 2045. Therefore, factors for example increasing occurrence of diabetes and increasing people with obesity will contribute to the high requirement for wound care biologics

𝐒𝐤𝐢𝐧 𝐬𝐮𝐛𝐬𝐭𝐢𝐭𝐮𝐭𝐞𝐬 𝐥𝐞𝐝 𝐭𝐡𝐞 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐚𝐧𝐝 𝐰𝐢𝐥𝐥 𝐠𝐫𝐨𝐰 𝐭𝐡𝐞 𝐟𝐚𝐬𝐭𝐞𝐬𝐭 𝐢𝐧 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞

This has a lot to do with the extensive usage of skin substitutes in chronic wound treatment. Human- and animal-based skin substitutes have a complete extracellular matrix construction and let the construction of natural dermis.

Furthermore, skin substitutes have excellent characteristics of re epithelialization. Also, hospitals and specialty clinics dominated the industry. The high requirement for wound care biologics in end-users is mostly because patients with chronic wounds need treatment under the direction of a trained healthcare professional.

Increasing use of permanent and temporary skin substitutes and increasing requirement for combination dressings, for instance, silver collagen and collagen hydrochloride for the prevention of microbial infection in injured areas are the main trends of the wound care biologics market.

Also, growing emphasis of pharma and biotech companies on new biologics is subsequent in the expansion of new, improved products that are providing support to the wound care specialists for the treatment of the acute and chronic wounds, which comprises of venous leg ulcers, diabetic foot ulcers, pressure ulcers, and surgical and burn injuries, in an improved way.


𝐒𝐎𝐔𝐑𝐂𝐄: 𝐏&𝐒 𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞